| Home> News & Events > Toronto Stock Exchange > News Release |
News Release
Response Biomedical Corp. To Trade On Toronto Stock Exchange
Response Biomedical Corp. (the “Company”) – An application has been granted for the original listing in the Industrial category of 155,067,877 common shares of the Company, of which 129,977,631 common shares are issued and outstanding, and 25,090,246 common shares are reserved for issuance.
The common shares of the Company will be listed and posted for trading at the opening on Friday, December 21, 2007.
The Company is subject to the reporting requirements of Section 501 of the TSX Company Manual.
Common Shares:
Stock Symbol: “RBM”
CUSIP: 76123L 10 5
Trading Currency: CDN
Designated Market Maker: Dundee Securities Corporation
Other Markets: The common shares of the Company have been listed on TSX Venture Exchange since April 9, 1984 and the OTC Bulletin Board under the symbol “RPBIF” since May 2005. The common shares will be delisted from TSX Venture Exchange on December 21, 2007, upon commencement of trading on TSX.
Head Office Address:
Suite 100 – 8900 Glenlyon Parkway
Burnaby, B.C
V5J 5J8
Website: www.responsebio.com
Email: info@responsebio.com
Head Office Telephone Number: (604) 456-6010
Fax Number: (604) 456-6066
Toll Free Number: 1-888-591-5577
Investors Relations:
Bill Wickson
Tel: (604) 456-6073
Email: bwickson@responsebio.com
Brian Korb
The Trout Group LLC
Tel: (646) 378-2923
Email: bkorb@troutgroup.com
Chief Financial Officer & Corporate Secretary: Robert G. Pilz
Incorporation: The Company was incorporated on August 20, 1980 under the predecessor to the Business Corporations Act (British Columbia).
Fiscal Year End: December 31
Nature of Business: The Company develops, manufactures and markets rapid on-site diagnostic tests for use with its portable RAMP Platform for clinical and environmental applications.
Transfer Agent & Registrar: Computershare Investor Services Inc. at its principal office in Toronto.
Dividends: The Company has not paid any dividends or made any distributions since incorporation. The Company does not anticipate paying dividends in the foreseeable future.
